Does the media favor SSII or AXGN?

In the previous week, SS Innovations International had 4 more articles in the media than AxoGen. MarketBeat recorded 9 mentions for SS Innovations International and 5 mentions for AxoGen. AxoGen's average media sentiment score of 1.08 beat SS Innovations International's score of 0.58 indicating that AxoGen is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SS Innovations International 2 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AxoGen 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor TMDX or SSII?

In the previous week, SS Innovations International had 3 more articles in the media than TransMedics Group. MarketBeat recorded 9 mentions for SS Innovations International and 6 mentions for TransMedics Group. SS Innovations International's average media sentiment score of 0.58 beat TransMedics Group's score of 0.57 indicating that SS Innovations International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TransMedics Group 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SS Innovations International 2 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to SSII or LMAT?

In the previous week, SS Innovations International had 4 more articles in the media than LeMaitre Vascular. MarketBeat recorded 9 mentions for SS Innovations International and 5 mentions for LeMaitre Vascular. SS Innovations International's average media sentiment score of 0.58 beat LeMaitre Vascular's score of 0.41 indicating that SS Innovations International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SS Innovations International 2 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LeMaitre Vascular 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor SSII or PLSE?

In the previous week, SS Innovations International had 6 more articles in the media than Pulse Biosciences. MarketBeat recorded 9 mentions for SS Innovations International and 3 mentions for Pulse Biosciences. Pulse Biosciences' average media sentiment score of 0.65 beat SS Innovations International's score of 0.58 indicating that Pulse Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SS Innovations International 2 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Pulse Biosciences 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

SS Innovations International (SSII) Competitors

$3.79 +0.01 (+0.26%)

Closing price 07/10/2026 04:00 PM Eastern

Extended Trading

$3.77 -0.02 (-0.53%)

As of 07/10/2026 07:41 PM Eastern

Compare

SSII vs. ESTA, AXGN, TMDX, LMAT, and PLSE

Should you buy SS Innovations International stock or one of its competitors? MarketBeat compares SS Innovations International with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SS Innovations International include Establishment Labs (ESTA), AxoGen (AXGN), TransMedics Group (TMDX), LeMaitre Vascular (LMAT), and Pulse Biosciences (PLSE). These companies are all part of the "medical equipment" industry.

How does SS Innovations International compare to Establishment Labs?

Establishment Labs (NASDAQ:ESTA) and SS Innovations International (NASDAQ:SSII) are both medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, valuation, analyst recommendations, profitability, media sentiment and risk.

In the previous week, SS Innovations International had 6 more articles in the media than Establishment Labs. MarketBeat recorded 9 mentions for SS Innovations International and 3 mentions for Establishment Labs. SS Innovations International's average media sentiment score of 0.58 beat Establishment Labs' score of 0.30 indicating that SS Innovations International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Establishment Labs	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
SS Innovations International	2 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

72.9% of Establishment Labs shares are held by institutional investors. 10.0% of Establishment Labs shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Establishment Labs presently has a consensus target price of $89.71, indicating a potential upside of 1.91%. SS Innovations International has a consensus target price of $7.00, indicating a potential upside of 84.70%. Given SS Innovations International's higher possible upside, analysts clearly believe SS Innovations International is more favorable than Establishment Labs.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

SS Innovations International has lower revenue, but higher earnings than Establishment Labs. SS Innovations International is trading at a lower price-to-earnings ratio than Establishment Labs, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$211.08M	12.27	-$51.06M	-$1.49	N/A
SS Innovations International	$42.49M	17.85	-$12.13M	-$0.05	N/A

Establishment Labs has a net margin of -19.05% compared to SS Innovations International's net margin of -20.69%. SS Innovations International's return on equity of -23.00% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-19.05%	-218.77%	-12.31%
SS Innovations International	-20.69%	-23.00%	-13.18%

Establishment Labs has a beta of 1.06, suggesting that its stock price is 6% more volatile than the broader market. Comparatively, SS Innovations International has a beta of -1.96, suggesting that its stock price is 296% less volatile than the broader market.

Summary

Establishment Labs beats SS Innovations International on 9 of the 16 factors compared between the two stocks.

How does SS Innovations International compare to AxoGen?

SS Innovations International (NASDAQ:SSII) and AxoGen (NASDAQ:AXGN) are both medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, media sentiment, institutional ownership and valuation.

SS Innovations International has a beta of -1.96, suggesting that its stock price is 296% less volatile than the broader market. Comparatively, AxoGen has a beta of 1.09, suggesting that its stock price is 9% more volatile than the broader market.

In the previous week, SS Innovations International had 4 more articles in the media than AxoGen. MarketBeat recorded 9 mentions for SS Innovations International and 5 mentions for AxoGen. AxoGen's average media sentiment score of 1.08 beat SS Innovations International's score of 0.58 indicating that AxoGen is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SS Innovations International	2 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AxoGen	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

80.3% of AxoGen shares are owned by institutional investors. 2.4% of AxoGen shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

AxoGen has a net margin of -13.21% compared to SS Innovations International's net margin of -20.69%. AxoGen's return on equity of -9.63% beat SS Innovations International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SS Innovations International	-20.69%	-23.00%	-13.18%
AxoGen	-13.21%	-9.63%	-6.26%

SS Innovations International presently has a consensus price target of $7.00, indicating a potential upside of 84.70%. AxoGen has a consensus price target of $46.50, indicating a potential upside of 14.59%. Given SS Innovations International's higher probable upside, research analysts plainly believe SS Innovations International is more favorable than AxoGen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
AxoGen	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73

SS Innovations International has higher earnings, but lower revenue than AxoGen. SS Innovations International is trading at a lower price-to-earnings ratio than AxoGen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SS Innovations International	$42.49M	17.85	-$12.13M	-$0.05	N/A
AxoGen	$238.11M	9.06	-$15.70M	-$0.64	N/A

Summary

AxoGen beats SS Innovations International on 11 of the 16 factors compared between the two stocks.

How does SS Innovations International compare to TransMedics Group?

TransMedics Group (NASDAQ:TMDX) and SS Innovations International (NASDAQ:SSII) are both medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability, valuation and risk.

TransMedics Group has higher revenue and earnings than SS Innovations International. SS Innovations International is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TransMedics Group	$605.49M	4.07	$190.29M	$4.40	16.19
SS Innovations International	$42.49M	17.85	-$12.13M	-$0.05	N/A

TransMedics Group has a beta of 1.89, indicating that its share price is 89% more volatile than the broader market. Comparatively, SS Innovations International has a beta of -1.96, indicating that its share price is 296% less volatile than the broader market.

TransMedics Group currently has a consensus price target of $134.50, indicating a potential upside of 88.82%. SS Innovations International has a consensus price target of $7.00, indicating a potential upside of 84.70%. Given TransMedics Group's stronger consensus rating and higher possible upside, equities analysts plainly believe TransMedics Group is more favorable than SS Innovations International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TransMedics Group	1 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

99.7% of TransMedics Group shares are owned by institutional investors. 6.9% of TransMedics Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, SS Innovations International had 3 more articles in the media than TransMedics Group. MarketBeat recorded 9 mentions for SS Innovations International and 6 mentions for TransMedics Group. SS Innovations International's average media sentiment score of 0.58 beat TransMedics Group's score of 0.57 indicating that SS Innovations International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TransMedics Group	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SS Innovations International	2 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

TransMedics Group has a net margin of 27.04% compared to SS Innovations International's net margin of -20.69%. TransMedics Group's return on equity of 22.38% beat SS Innovations International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TransMedics Group	27.04%	22.38%	8.46%
SS Innovations International	-20.69%	-23.00%	-13.18%

Summary

TransMedics Group beats SS Innovations International on 13 of the 16 factors compared between the two stocks.

How does SS Innovations International compare to LeMaitre Vascular?

SS Innovations International (NASDAQ:SSII) and LeMaitre Vascular (NASDAQ:LMAT) are both medical equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, valuation, analyst recommendations, profitability, earnings and risk.

LeMaitre Vascular has a net margin of 24.35% compared to SS Innovations International's net margin of -20.69%. LeMaitre Vascular's return on equity of 15.36% beat SS Innovations International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SS Innovations International	-20.69%	-23.00%	-13.18%
LeMaitre Vascular	24.35%	15.36%	9.78%

LeMaitre Vascular has higher revenue and earnings than SS Innovations International. SS Innovations International is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SS Innovations International	$42.49M	17.85	-$12.13M	-$0.05	N/A
LeMaitre Vascular	$249.60M	9.41	$57.73M	$2.71	37.91

In the previous week, SS Innovations International had 4 more articles in the media than LeMaitre Vascular. MarketBeat recorded 9 mentions for SS Innovations International and 5 mentions for LeMaitre Vascular. SS Innovations International's average media sentiment score of 0.58 beat LeMaitre Vascular's score of 0.41 indicating that SS Innovations International is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SS Innovations International	2 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LeMaitre Vascular	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

SS Innovations International has a beta of -1.96, suggesting that its share price is 296% less volatile than the broader market. Comparatively, LeMaitre Vascular has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market.

SS Innovations International currently has a consensus price target of $7.00, indicating a potential upside of 84.70%. LeMaitre Vascular has a consensus price target of $112.60, indicating a potential upside of 9.60%. Given SS Innovations International's higher possible upside, equities analysts plainly believe SS Innovations International is more favorable than LeMaitre Vascular.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
LeMaitre Vascular	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

84.6% of LeMaitre Vascular shares are held by institutional investors. 7.4% of LeMaitre Vascular shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

LeMaitre Vascular beats SS Innovations International on 12 of the 16 factors compared between the two stocks.

How does SS Innovations International compare to Pulse Biosciences?

SS Innovations International (NASDAQ:SSII) and Pulse Biosciences (NASDAQ:PLSE) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, earnings, profitability, risk and dividends.

SS Innovations International has higher revenue and earnings than Pulse Biosciences. SS Innovations International is trading at a lower price-to-earnings ratio than Pulse Biosciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SS Innovations International	$42.49M	17.85	-$12.13M	-$0.05	N/A
Pulse Biosciences	$751K	2,422.81	-$72.78M	-$1.10	N/A

SS Innovations International has a beta of -1.96, indicating that its share price is 296% less volatile than the broader market. Comparatively, Pulse Biosciences has a beta of 1.65, indicating that its share price is 65% more volatile than the broader market.

SS Innovations International currently has a consensus price target of $7.00, indicating a potential upside of 84.70%. Pulse Biosciences has a consensus price target of $30.67, indicating a potential upside of 16.65%. Given SS Innovations International's higher probable upside, research analysts plainly believe SS Innovations International is more favorable than Pulse Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Pulse Biosciences	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Pulse Biosciences has a net margin of 0.00% compared to SS Innovations International's net margin of -20.69%. SS Innovations International's return on equity of -23.00% beat Pulse Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SS Innovations International	-20.69%	-23.00%	-13.18%
Pulse Biosciences	N/A	-86.67%	-73.61%

In the previous week, SS Innovations International had 6 more articles in the media than Pulse Biosciences. MarketBeat recorded 9 mentions for SS Innovations International and 3 mentions for Pulse Biosciences. Pulse Biosciences' average media sentiment score of 0.65 beat SS Innovations International's score of 0.58 indicating that Pulse Biosciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SS Innovations International	2 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Pulse Biosciences	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

76.9% of Pulse Biosciences shares are owned by institutional investors. 74.0% of Pulse Biosciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Pulse Biosciences beats SS Innovations International on 9 of the 16 factors compared between the two stocks.

Get SS Innovations International News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SSII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SSII vs. The Competition

Export

Metric	SS Innovations International	Technology Services Industry	Business Sector	NASDAQ Exchange
Market Cap	$758.50M	$4.09B	$6.91B	$12.66B
Dividend Yield	N/A	2.20%	3.13%	8.00%
P/E Ratio	-75.80	37.33	29.27	24.53
Price / Sales	17.85	46.88	347.65	95.90
Price / Cash	N/A	36.49	23.47	60.03
Price / Book	18.95	4.29	5.74	6.38
Net Income	-$12.13M	$31.76M	$204.80M	$331.87M
7 Day Performance	0.26%	-1.88%	-1.41%	0.35%
1 Month Performance	12.80%	-5.41%	1.46%	0.57%
1 Year Performance	-24.05%	6.34%	16.36%	22.26%

SS Innovations International Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SSII SS Innovations International	2.2952 of 5 stars	$3.79 +0.3%	$7.00 +84.7%	-24.0%	$758.50M	$42.49M	N/A	4	Gap Up
ESTA Establishment Labs	1.1788 of 5 stars	$89.25 flat	$87.14 -2.4%	+96.1%	$2.63B	$211.08M	N/A	1,004	Analyst Forecast
AXGN AxoGen	2.7603 of 5 stars	$45.89 flat	$46.50 +1.3%	+241.3%	$2.44B	$225.21M	N/A	450	News Coverage Positive News Gap Down
TMDX TransMedics Group	4.3298 of 5 stars	$68.86 flat	$134.50 +95.3%	-36.7%	$2.38B	$605.49M	15.65	210
LMAT LeMaitre Vascular	3.8172 of 5 stars	$102.88 flat	$112.60 +9.4%	+22.8%	$2.35B	$249.60M	37.96	490	Positive News Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SSII) was last updated on 7/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SS Innovations International (SSII) Competitors

SSII vs. ESTA, AXGN, TMDX, LMAT, and PLSE

How does SS Innovations International compare to Establishment Labs?

Summary

How does SS Innovations International compare to AxoGen?

Summary

How does SS Innovations International compare to TransMedics Group?

Summary

How does SS Innovations International compare to LeMaitre Vascular?

Summary

How does SS Innovations International compare to Pulse Biosciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SSII vs. The Competition

SS Innovations International Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

SS Innovations International (SSII) Competitors

SSII vs. ESTA, AXGN, TMDX, LMAT, and PLSE

How does SS Innovations International compare to Establishment Labs?

Does the media refer more to ESTA or SSII?

Do insiders & institutionals have more ownership in ESTA or SSII?

Do analysts recommend ESTA or SSII?

Which has stronger earnings and valuation, ESTA or SSII?

Is ESTA or SSII more profitable?

Which has more volatility and risk, ESTA or SSII?

Summary

How does SS Innovations International compare to AxoGen?

Which has more risk and volatility, SSII or AXGN?

Does the media favor SSII or AXGN?

Do insiders & institutionals believe in SSII or AXGN?

Is SSII or AXGN more profitable?

Do analysts rate SSII or AXGN?

Which has stronger earnings & valuation, SSII or AXGN?

Summary

How does SS Innovations International compare to TransMedics Group?

Which has stronger valuation and earnings, TMDX or SSII?

Which has more risk and volatility, TMDX or SSII?

Do analysts prefer TMDX or SSII?

Do insiders and institutionals believe in TMDX or SSII?

Does the media favor TMDX or SSII?

Is TMDX or SSII more profitable?

Summary

How does SS Innovations International compare to LeMaitre Vascular?

Is SSII or LMAT more profitable?

Which has preferable earnings & valuation, SSII or LMAT?

Does the media refer more to SSII or LMAT?

Which has more volatility & risk, SSII or LMAT?

Do analysts recommend SSII or LMAT?

Do insiders and institutionals have more ownership in SSII or LMAT?

Summary

How does SS Innovations International compare to Pulse Biosciences?

Which has stronger earnings & valuation, SSII or PLSE?

Which has more risk & volatility, SSII or PLSE?

Do analysts recommend SSII or PLSE?

Is SSII or PLSE more profitable?

Does the media favor SSII or PLSE?

Do institutionals and insiders have more ownership in SSII or PLSE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SSII vs. The Competition

SS Innovations International Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools